Effect of high-glucose levels on protein oxidation in cultured lens cells, and in crystalline and albumin solution and its inhibition by vitamin B6 and N-acetylcysteine: its possible relevance to cataract formation in diabetes

Free Radic Biol Med. 2002 Dec 15;33(12):1615-21. doi: 10.1016/s0891-5849(02)01109-7.

Abstract

Diabetic patients have elevated levels of glucose in their blood and other body fluids. This project studied the effect of high-glucose concentrations (HG) on the protein oxidation in cultured lens cells and in crystalline protein solution. In addition, we also examined the effect of HG on the oxidation and turbidity (aggregation) of albumin protein solution. This study also examined whether vitamin B6 [pyridoxine (P), pyridoxamine (PM)] or n-acetylcysteine (NAC) is capable of preventing protein oxidation similar to that seen in cataracts. For cell culture studies, rabbit lens cells were cultured in control or HG medium at 37 degrees C for 2 d. For studies with protein solution, a buffered solution of serum albumin or crystalline protein was incubated with normal glucose (5 mM) or HG (50-100 mM) in a water bath at 37 degrees C for 4 d. All treatments were carried out with and without the addition of P, PM, or NAC. We found significantly higher levels of carbonyl protein (an index of protein oxidation) in HG-treated compared with normal glucose-treated lens cells and in crystalline protein solution. P, PM, and NAC significantly decreased the protein oxidation in lens cells and crystalline protein solution. We also found significantly higher levels of protein oxidation and turbidity (an index of protein aggregation) and its inhibition by P, PM, and NAC in HG-treated compared with normal glucose-treated albumin solution. This suggests that HG can cause the oxidation and modification of proteins in the lens, and that vitamin B6 and NAC supplementation may be helpful in slowing the oxidation of lens proteins. This study explains the cause of early cataract development and the potential benefit of supplementation with vitamin B6 and NAC in the prevention of the development of cataract among the diabetic population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology*
  • Albumins / metabolism
  • Animals
  • Cataract / chemically induced
  • Cataract / complications*
  • Cataract / metabolism
  • Cataract / pathology
  • Cells, Cultured
  • Diabetes Complications*
  • Diabetes Mellitus / metabolism
  • Dose-Response Relationship, Drug
  • Glucose / antagonists & inhibitors
  • Glucose / pharmacology*
  • Lens, Crystalline / cytology
  • Lens, Crystalline / drug effects*
  • Lens, Crystalline / metabolism
  • Nephelometry and Turbidimetry
  • Oxidants / antagonists & inhibitors
  • Oxidants / pharmacology*
  • Oxidation-Reduction / drug effects
  • Proteins / metabolism*
  • Rabbits
  • Vitamin B 6 / pharmacology*

Substances

  • Albumins
  • Oxidants
  • Proteins
  • Vitamin B 6
  • Glucose
  • Acetylcysteine